Fascinating preprint (H/T @zeynep ) - in host diversity is quite limited (i.e. variants aren't emerging from typical infections spreading)
This really brings up the concept of making sure our immunocompromised patients are followed up appropriately, and vaccines are pushedhttps://twitter.com/KATarinambraun/status/1388312255222124544 …
-
-
we put together this document in http://indiacovidsos.org with
@paimadhu@KrutikaKuppalli for just pragmatic care at home and eliminating therapies that don't work. There is also a great evidence review at https://www.covid19treatmentguidelines.nih.gov/whats-new/ including plasma. -
WHO guidance is here: https://www.bmj.com/content/370/bmj.m3379 … They're a bit behind on some therapies (tociluzimab, plasma) but from what I hear it's coming soon!
@Bram_Rochwerg - Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
We deep seq’d
carefully at long-term infxs.
1/12